Mesa Laboratories (MLAB) Misses Q4 EPS by 229c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MLAB Hot Sheet
Price: $126.19 +0.57%
Financial Fact:
Earnings Before Income Taxes: 3.21M
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Earnings Before Income Taxes: 3.21M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Mesa Laboratories (NASDAQ: MLAB) reported Q4 EPS of ($0.75), $2.29 worse than the analyst estimate of $1.54. Revenue for the quarter came in at $63.72 million versus the consensus estimate of $65.2 million.
For earnings history and earnings-related data on Mesa Laboratories (MLAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- JPMorgan Downgrades Nemak SAB de CV (NEMAKA:MM) (NMAKF) to Underweight
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
